Introduction
============

Visual impairment is observed in 3% of preterm infants born before 37 weeks GA. The main related causes are ROP, refractive ametropia, strabismus, and visual cortex involvement. The risk of visual impairment is higher when the prematurity is more important. [@B8] showed 2.1% of blindness, 4.8% of visual impairment according to the World Health Organization in a cohort of infants born before 27 weeks GA at the 6.5-year follow-up. Moreover, they presented in comparison with the term control children group at age 6.5 years 17.4% vs. 0% of strabismus, 29.7% vs. 5.9% of refractive errors, 37.5% vs. 6.2% of ophthalmologic abnormalities ([@B8]).

Visual development occurs in three steps. The first step is the anatomical formation of the eye, which is influenced by genetics; the second step is the visual experience related to endogenous stimulation *in utero*; and the third step is the visual experience by exogenous stimulation after birth ([@B7]). Thus, VPI are at high risk of visual development vulnerabilities because the second step of development is curtailed and the third step begins in an immature system. Moreover, at 2 years of age, VPI born before 27 weeks GA with visual impairment have more psychomotor delay than those without visual impairment ([@B9]). Therefore, visual maturation, defined as retinal, globe, vascular and non-vascular structures growth, and factors influencing this development are important in this population and have to be taken into consideration. However, the normal visual development in premature infants and the impact of the factors that influence it are poorly understood.

The aim of this study was to describe visual maturation of VPI at TEA and to investigate factors associated with impaired visual maturation.

Materials and Methods {#s1}
=====================

Subjects
--------

In our level III NICU, all preterm infants born before 32 weeks GA undergo routine MRI and an ophthalmological evaluation at TEA as part of their follow-up. Infants with a MRI scheduled between February and June 2016 were included in the present observational study. Infants with a genetic syndrome, ocular abnormality, facial malformation, or craniosynostosis were excluded.

Primary Outcome
---------------

Primary outcome was the measurement of visual acuity at TEA. Given the early age of the infants, we measured discriminative visual acuity in cycles/degree using the preferential looking method and Baby-Vision^®^ acuity cards (Tropique, Paris, France) ([@B22]). The infants sat on the lap of an adult as the examiner presented them with a series of cards. As appropriate for the age of the infants, the distance of the examination was 40 cm from the child. All examinations were carried out by the same investigator in the same quiet room with a bright and monotonous visual environment.

The examination was performed in binocular vision. The exam began with a low-frequency spatial acuity card and continued until the wandering glance. The answer was considered positive when the cards were perceived by the child. In response to a negative or doubtful answer, the examiner showed the previous cards again until the highest card was acknowledged. The visual acuity was that for which at least three of four responses were obtained.

Secondary Outcomes
------------------

### Visual Maturation Evaluation

Visual maturation evaluation included clinical eye examination evaluating the ocular anatomy (appearance of the eyeballs, pupillary reflections, corneal aspect, palpebral aspect, appearance of sclera, conjunctiva, and iris). Signs of visual deficit were sought. Ocular motricity was evaluated in binocular vision.

Different reflexes were evaluated, including attraction to light, direct and consensual photomotor reflex, reflex of closing the eyelids to glare, fixation reflex, reflex of blinking to the threat, eye pursuit, reflex of convergence. Refraction was measured by an autorefractometer (Retinomax 3^®^, Righton, United States) under cycloplegia using 0.5% tropicamide drops. A retinal camera (RetCam Shuttle^®^, Clarity Medical Systems, United States) was used for FE as part of a longitudinal evaluation in the context of the routine screening and follow-up of ROP. It allowed to evaluate the maturation of the retinal vascularization, specifically with the completeness or incompleteness of the vascularization up to the ora serrata, the presence of ROP, and papillary excavation.

### Neuroradiology

We also evaluated cerebral MRI data at TEA. Prior to undergoing MRI, each infant was fed, wrapped in a blanket, and placed (not sedated) in a 1.5 Tesla Vantage Titan^®^ of Toshiba tunnel with cardiac frequency and oxygen saturation monitoring. MRI was categorized as "MRI globally normal" or "MRI globally abnormal" when lesions were present, such as supra-tentorial injury (sequelae of germinal matrix hemorrhage, subependymal hemorrhage, and diffuse or cystic periventricular leukomalacia) and sub-tentorial or fossa posterior lesions. The following indices of cerebral volume were measured: CSI and VSA ([@B13]).

Clinical and Pharmacological Data
---------------------------------

Data related to the perinatal period were collected from the infants' medical files in a standardized manner. The characteristics of the infants (GA, gender, Apgar score, weight and head circumference at birth and TEA), the therapies used and the major complications of prematurity PDA, intraventricular hemorrhage diagnosed by intracranial ultrasound and defined according to Papile's classification ([@B16]), cystic periventricular leukomalacia diagnosed by MRI, BPD defined by [@B11], ROP according to the international classification ([@B10]), necrotizing enterocolitis defined by [@B1], early onset sepsis defined by sepsis ≤ 3 days of birth and late onset sepsis defined by sepsis \> 3 days of birth, blood inflammation defined by C-reactive protein \> 30 mg/l or Interleukin-6 \> 250 μg/l, nutrition during the infants hospitalization classified by breastfeeding, artificial milk or mixed feeding, and the duration of neonatal hospitalization were recorded.

Statistical Analysis
--------------------

Visual acuity and secondary outcomes were described first. Data are presented as mean ± SD, or median and interquartile range and range. Next, visual acuity was compared to published reference data for children born at term ([@B20]). In order to compare the individual relationships between visual maturation and the perinatal environment, parametric (Student's T, ANOVA, chi-square) and non-parametric tests (Mann and Whitney, Kruskal--Wallis, Fisher exact) were used when appropriate. To determine which variables were associated with visual acuity, bivariate and multivariate linear regression analyses were performed. Only the factor presenting a significant association at the threshold of 0.2 in the bivariate model were included in the multivariate model with the stepwise method (SLE = 0.2; SLS = 0.05). The threshold for significance was set at 5%. These analyses were performed by the clinical research support facility of the Nancy CHRU (Unit of Methodology, Data Management, and Statistics) using SAS v9.4 software (SAS Institute, Cary, NC, United States).

Ethics Statement
----------------

This prospective observational study was approved by our institutional review board (DRI, CHRU Nancy: PSS2016/PREMAVISION) and registered with the Commission Nationale Informatique et Libertés (number: R2016-02) and [ClinicalTrials.gov](https://clinicaltrials.gov) (number: NCT02890251). Both parents were informed that the data will be used for research purposes and their consent obtained in writing and signed. The research followed the tenets of the Declaration of Helsinki.

Results
=======

Population Characteristics
--------------------------

Fifty-four infants were studied. The characteristics of our population in the neonatal period and at TEA evaluation are presented in Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, respectively. The duration of neonatal hospitalization was 68.5 ± 21.8 days.

###### 

Neonatal characteristics of the study population (*N* = 54).

  Variable                                           *N*     \% or mean ±*SD*
  -------------------------------------------------- ------- ------------------
  Gestational age (weeks GA)                         54      29.5 ± 1.7
  Birthweight (grams)                                54      1194 ± 288
  Head circumference at birth (cm)                   54      26.4 ± 1.9
  Male                                               26      48.1
  Apgar score at 1 min after birth                   54      4.8 ± 2.5
  Apgar score at 5 min after birth                   54      6.8 ± 1.5
  Antenatal corticosteroid                           50/54   92.6
  Intraventricular hemorrhage                        8       14.8
  Periventricular leukomalacia                       0       0
  Mechanical ventilation                             50      92.6
  Bronchopulmonary dysplasia                         28      51.9
  Mild                                               12      42.9
  Moderate                                           13      46.4
  Severe                                             3       10.7
  Surgery for patent ductus arteriosus               5       9.3
  Early onset infection                              4       7.4
  Late onset infection                               16      29.6
  Blood inflammation                                 16      29.6
  Jaundice                                           45      83.3
  Necrotizing enterocolitis, all stages              8/53    15.1
  ROP, all stages                                    13/52   25.0
  Maternal smoking during pregnancy                  16/53   30.2
  Maternal consumption of alcohol during pregnancy   2/53    3.8
  Exclusive breastfeeding                            18      33.3
  Exclusive artificial feeding                       1       1.9
  Mixed feeding                                      35      64.8
                                                             

###### 

Characteristics of the study population at evaluation.

                                               *N*     \%     Mean   *SD*   Median   Q1     Q3     Minimum   Maximum
  -------------------------------------------- ------- ------ ------ ------ -------- ------ ------ --------- ---------
  Age (days)                                   54             90     15     89       81     95     64        133
  Corrected age (weeks GA)                     54             42.3   1.6    42.4     41.3   43.3   38.9      47.6
  Weight (g)                                   54             3381   535    3370     2980   3780   2420      4400
  Head circumference (cm)                      54             35.8   1.4    36.0     35.0   36.8   32.0      38.5
  Ophthalmologic family history                37/52   71.2                                                  
  Eyelid anomalies                             7/54    13                                                    
  Cornea anomalies                             0/54    0                                                     
  Sclera anomalies                             0/54    0                                                     
  Conjunctiva anomalies                        0/54    0                                                     
  Iris anomalies                               0/54    0                                                     
  Eyeballs anomalies                           0/54    0                                                     
  Pupillary reflections anomalies              0/54    0                                                     
  Signs of visual deficit                      0/54    0                                                     
  Eye pursuit anomalies                        0/54    0                                                     
  Attraction to light                          54/54   100                                                   
  Closure of the eyelids to glare              53/54   98.1                                                  
  Reflex of blinking to the threat             49/53   92.5                                                  
  Reflex of convergence                        8/53    15.1                                                  
  Reflex of fixation                           54/54   100                                                   
  Binocular visual acuity (cycles/degree)      52             1.5    0.7    1.6      0.8    1.9    0.5       2.4
  Refraction, sphere, right eye (D)            54             3.5    1.7    3.4      2.8    4.5    -1.0      7.5
  Refraction, cylinder, right eye (D)          54             -1.5   1.0    -1.3     -2.3   -0.5   -4.3      -0.3
  Refraction, sphere, center eye (D)           54             3.3    1.7    3.1      2.3    4.3    -0.8      8.5
  Refraction, cylinder, center eye (D)         54             -1.4   0.9    -1.3     -1.8   -0.8   -4.3      0.0
  Sphere difference between the 2 eyes (D)     54             0.9    0.7    0.7      0.5    1.3    0.0       2.7
  Cylinder difference between the 2 eyes (D)   54             0.8    0.7    0.7      0.3    1.0    0.0       3.0
  Incomplete retinal vascularization           29/53   54.7                                                  
  Papillary excavation                         0/53    0                                                     
  ROP at TEA                                   5/53    9.4                                                   
  Pathological MRI                             16/54   31.5                                                  
  Subtentorial or fossa posterior lesions      7/54    13.0                                                  
  Sustentorial lesions                         15/54   27.8                                                  
  VSA                                          54             7285   595    7263     6958   7612   5908      8642
  CSI                                          54             1.0    0.0    1.0      1.0    1.0    0.9       1.0
                                                                                                             

Visual Acuity
-------------

Visual acuity was higher in premature infants at TEA than in the reference with term newborns at birth (1.54 ± 0.67 vs. 0.99 ± 0.40 cycles/degree, *p* = 0.008). No relationship was found between visual acuity and actual age or corrected age in VPI. Potential associated factors with higher visual acuity in bivariate analyses and included in the multivariate analysis are presented Table [3](#T3){ref-type="table"}. Of note, the refraction of the two eyes in combined analysis did not reveal an impact of the sphere, but it did reveal a significant impact of the cylinder (right eye *r* = 0.031, left eye *r* = 0.219; *p* = 0.004).

###### 

Visual acuity (cycles/degree) by risk factors in bivariate analysis.

  Variables                                          Yes         No          *r*       *p*
  -------------------------------------------------- ----------- ----------- --------- -------
  Intraventricular hemorrhage                        1.2 ± 0.6   1.6 ± 0.7             0.150
  Early onset infection                              0.9 ± 0.4   1.6 ± 0.7             0.060
  Maternal consumption of alcohol during pregnancy   0.8 ± 0.0   1.6 ± 0.7             0.111
  Pathological MRI                                   1.3 ± 0.3   1.6 ± 0.7             0.065
  Subtentorial or fossa posterior lesions            1.1 ± 0.5   1.6 ± 0.7             0.157
  Weight at the time of evaluation                                           0.0003    0.139
  Higher cerebral VSA                                                        0.003     0.068
  Smaller CSI                                                                -15.061   0.176
                                                                                       

r, regression coefficient in simple linear regression; p, p-value

There was no significant association with the other factors studied (*p* \> 0.2).

In multivariate analysis, abnormal brain MRI was the only factor associated with visual acuity (*r*^2^= 0.203, *p* = 0.026).

Other Visual Development Parameters
-----------------------------------

No infant had signs of visual impairment. Among the observed palpebral abnormalities, 6 infants had bilateral port wine stains and 1 had a left eyelid hidrocystoma. No other morphological abnormalities were found. Eye pursuit was normal in all patients. FE revealed vascular tortuosity in three cases. No infant had papillary excavation, with a cup/disk ratio ≤0.2 in all cases.

Retinal vascularization at TEA was completed in only 24 of the premature infants. Incomplete retinal vascularization was associated with MRI abnormalities of the posterior fossa (*p* = 0.027) and a larger refractive sphere difference between both eyes (1.2 ± 0.8 vs. 0.6 ± 0.4 diopters; *p* = 0.0005). The Spearman correlation test did not demonstrate a correlation between head circumference at birth and the refractive measurements, or between head circumference at TEA and refractive measurements. However, a correlation of *r* = 0.306 (*p* = 0.024) was measured between head circumference at birth and at TEA, and a correlation of *r* = 0.275 (*p* = 0.044) between head circumference at birth and the refractive sphere difference between both eyes at TEA. Palpebral abnormalities were not significantly related to the refractive data. The blink reflex to the threat appeared to be associated with an absence of ROP at TEA (*p* = 0.042). We did not find any significant correlation between the glare reflex and environmental factors. The convergence reflex was related to the actual age at the time of the assessment; it was present at an average age of 99.1 ± 18 days and absent at an average age of 88 ± 13.7 days (*p* = 0.049). Regarding postconceptional age, it was present at an average age of 43.4 ± 2.3 weeks GA and absent at an average age of 42.1 ± 1.4 weeks GA (*p* = 0.076). No significant relationship was found with environmental factors.

Retinopathy of Prematurity (ROP)
--------------------------------

Thirteen of our patients had ROP in the neonatal period; they were born more premature (27.8 ± 1.6 vs. 30.0 ± 1.5 weeks GA, *p* = 0.0001) and with a lower birth weight (1002 ± 315 vs. 1248 ± 256 g; *p* = 0.007). In addition, they had longer duration of mechanical ventilation (11.4 ± 10.8 vs. 4.1 ± 5.4 days; *p* = 0.002), more moderate and severe BPD (80% vs. 29.4% and 20% vs. 5.9%, respectively; *p* = 0.001), more surgery for PDA (30.8% vs. 2.6%, *p* = 0.011), and more late onset infections (53.8% vs. 20.5%, *p* = 0.034). The maximum ROP stage, with both eyes combined, was stage 1 in 7.7% of infants, stage 2 in 61.5% of infants, and stage 3 in 30.8% of infants. The most severe zone reached with both eyes combined was zone II in 69.2% of cases and zone III in 30.8% of cases. For the five cases of ROP observed at TEA, the maximum stage was stage 1 in 1 infant and stage 2 in 4 infants. The most severe zone was zone II in 1 infant and zone III in 4 infants. Asymmetry of the ROP between both eyes was noted. No ROP treatment was necessary in our population. ROP in VPI was significantly associated with indicators of smaller cerebral volume (VSA = 6981.1 ± 606.2 vs. 7387.7 ± 579.0; *p* = 0.035).

Discussion
==========

Visual acuity was higher in premature infants at TEA than in term newborns at birth as reported by the Vital-Durand study ([@B20]). These studies are relevant for a comparison with our population because of the comparability of the measurement of visual acuity by the preferential looking method ([@B21]). This result is consistent with [@B18] who showed that visual acuity of preterm infants born ≤ 36 weeks GA was better than full-term infants born \> 36 weeks GA. Moreover, visual acuity development in healthy preterm infants appears to be accelerated when compared with full-term infants of the same post-conceptional age ([@B18]). This result may be related to a longer exogenous visual experience from birth in the VPI, to the contrary of the study of [@B23] who showed that additional visual experience of preterm infants born after 31 weeks GA did not influence development of visual acuity during the 1st months of life.

[@B18] showed that acuity development of normal preterm infants was related to post-conceptional age rather than actual age. Accordingly, we did not find an effect of the actual age at TEA on visual parameters in our population. A critical period for the onset of visual maturation is suggested in VPI. The neurological pathways of the retina are active between 22 and 40 weeks GA and may begin to function before the organization of sleep, which appears at approximately 28--30 weeks GA. Their organization occurs during sleep in the dark ([@B7]). However, total permanent darkness is deleterious for visual development; visual experience in the 1st months of life is essential for the development of visual function ([@B12]). Newborns exposed to a day and night luminous rhythm open their eyes more than those exposed to continuous light stimulation ([@B17]). The entry of light into the eye is likely not limited in premature infants before 32 weeks PMA, as the eyelids are thin and often open ([@B7]). In our unit, we cover the incubators with a cloth in order to reduce the ambient brightness, especially direct exposure of the retina to strong light, which is known to be toxic ([@B14]). In addition, the ambient lights are softened at night to facilitate sleep/wake rhythms. Thus, when the eyelids are closed, the children may have better darkness, which could lead to better organization of the retinal neurological pathways. The eyelids are closed for 55% of the time among those under 26 weeks GA, 93% of the time at 28 weeks GA, and 60% of the time at 34 weeks GA ([@B17]; [@B5]). Therefore, the beginning of the critical period of visual maturation is likely around 28 weeks postmenstrual age (PMA). The number of patients is insufficient to show this developmental threshold effect at an intermediate age between 24 and 32 weeks, but this point should be taken into consideration in subsequent studies.

We only found an association between a lower visual acuity and abnormal cerebral MRI, without a significant specific link with the occipital area. This may be due to the small size of our population and a lack of power. Padilla et al reported significant global reductions in the brain tissue of premature infants born before 27 weeks GA but observed specific increases in cortical gray and white matter involving vision-related brain areas ([@B15]).

Cerebral imaging is interesting for assessing the development of vision ([@B2]; [@B15]; [@B13]). The cerebral volume seems related to visual development and the occurrence of abnormalities. Cerebral volume indices such as VSA, which is a standardized spherical surface area calculation ([@B13]), was significantly associated with visual acuity in the multivariate analysis. Given the interest of the VSA and the link between the development of the posterior fossa and the retina, it would be helpful to develop an indicator of occipital brain volume development. Beyond the usefulness of the VSA in physiological visual maturation, this indicator seems to provide meaningful information in pathological situations, as it is significantly lower with ROP. [@B19] showed a relation between ROP and lower cerebellar volume and lower unmyelinated white matter volume at TEA. Moreover, [@B4] showed an association between severe ROP and reduced cerebellar and brainstem volumes measured by automatic segmentation method at TEA. Both of those studies concluded to neurodevelopmental deficits at 2 years ([@B4]; [@B19]). For medical teams that do not have these measurement techniques available, VSA is an easy to measure indicator in routine MRI. We were not able to evaluate the measurements of optical radiation, particularly because of the poor quality of the diffusion images. It would be interesting to evaluate the occipital area specifically, particularly by fractional anisotropy measurements ([@B2]) or functional brain imaging ([@B15]).

None of our patients showed signs of visual impairment at TEA. Although strabismus is more frequent in VPI ([@B3]) the absence of strabismus in our population at TEA may be due to the too young actual age of our infants. Strabismus is an abnormality of binocular vision, which is set up between 3 and 5 months of life ([@B3]; [@B14]); thus, being able to diagnose it prior to that age is unlikely.

The convergence reflex usually appears after 4 months. The timing of the appearance of visual reflexes in VPI is not documented in the literature. Our results suggest that visual reflexes appear according to the actual age and not the corrected age because the convergence reflex tends to appear when approaching 4 months of actual age and not corrected age. [@B23] suggested that convergence reflex depends on postconceptional age in low preterm infants. However, this difference can be explained by the difference of population as we studied more immature infants and because only 8 infants of our cohort had a convergence reflex at TEA.

Angiogenesis of the retina and brain visual pathway seems to play an important role in visual maturation. Of note, 54.7% of our VPI's retinal vascularization were surprisingly yet not completed at TEA. In our study, incomplete vascularization was associated with larger refractive sphere difference. So, it is possible that the vascularization has a role on the development of the eyeballs and thus on the refractive parameters of the eyes. Retinal vascularization is never strictly symmetrical, as in the asymmetry of ROP. [@B8] showed more anomalies of spherical equivalents at 30 months corrected age when infants had ROP with an effect of the severity of ROP. We did not highlight this element, perhaps because of the low prevalence of ROP in our cohort. The impact of retinal angiogenesis on volume development in the eyes of VPI would be interesting to evaluate. The incomplete retinal vascularization of VPI at TEA seems to be predictive of anisometropia.

Contrary to the results of [@B6], we did not find a link between visual maturation at TEA and jaundice. This can be explained by the fact that none of our jaundice patients exceeded the neurotoxic threshold and were all treated with phototherapy.

The visual acuity at TEA was not different when ROP was present in the neonatal period. Because the macula is the precise vision area containing the largest number of cones and located in zone I, and none of the ROP in our population was in this zone, our finding seems to be consistent with previous data. Nevertheless, it would be interesting to evaluate the visual field at a later age.

Our study has limitations. First, the number of patients was rather small. Even though we found a number of significant associations, the non-significant trends we observed may be due to a lack of statistical power. Second, cycloplegia was performed using tropicamide due to contraindications at this age and the toxicity of other cycloplegic drugs in the context of prematurity. Tropicamide may be a less reliable cycloplegic drug and does not allow the establishment of optical correction at the age of our population. Whether the refraction performed at TEA by tropicamide can be predictive of abnormalities confirmed by a more reliable cycloplegic drug in follow-up would be interesting to assess, as it would allow greater vigilance and implementation of earlier treatment for the prevention of amblyopia.

Conclusion
==========

The critical period of onset of visual maturation of VPI remains to be defined. Evaluating the continuation of visual maturation in these VPI in order to obtain reference values for this population is important, as well as following the evolution of the visual parameters and defining any predictive elements of future amblyopia in order to improve care. A follow-up of our cohort is planned at 18 months corrected age, 4 and 7 years.
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BPD

:   bronchopulmonary dysplasia

CSI

:   Cortex Skull Index

FE

:   fundus examination

GA

:   week's gestation

MRI

:   magnetic resonance imaging

PDA

:   patent ductus arteriosus

ROP

:   retinopathy of prematurity

SD

:   standard deviation

TEA

:   term equivalent age

VPI

:   very preterm infants

VSA

:   Volume Slice Area
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